Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S ANALYSIS
5 REGULATORY FRAMEWORK
5.1 REGULATORY GUIDANCE AS PER U.S. FDA.
5.2 REGULATORY SCENARIO FOR EUROPEAN UNION
5.3 REGULATORY SCENARIO IN JAPAN
5.4 REGULATORY FRAMEWORK IN CHINA
6 PIPELINE ANALYSIS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 PRODUCT APPROVAL OF SMALL MOLECULE
7.1.3 HIGH R&D INVESTMENT FOR SMALL MOLECULE DEVELOPEMNT
7.1.4 STRONG PIPELINE FOR SMALL MOLECULE INJECTABLE
7.1.5 GROWTH IN GENERIC INJECTABLES
7.2 RESTRAINTS
7.2.1 HIGH LEVEL OF QUALITY AND CARE REQUIRED IN THE PRODUCTION
7.2.2 HIGH MANUFACTURING AND PURCHASING COST OF INJECTABLES
7.2.3 STRINGENT REGULATIONS FOR FACILITES AND EQUIPMENTS REQUIRED FOR SMALL MOLECULES INJECTABLE
7.2.4 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
7.3.2 GROWING PRODUCT LAUNCHES
7.3.3 RISING PER CAPTIA INCOME AND HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF ACCESSIBILITY
7.4.2 HIGH COST OF DIAGNOSIS & TREATMENT
8 IMPACT OF COVID-19 ON THE NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
8.1 OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
8.2 IMPACT ON PRICE
8.3 IMPACT ON DEMAND
8.4 IMPACT ON SUPPLY CHAIN
8.5 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
8.6 CONCLUSION
9 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 VIAL FILLING
9.3 SYRINGE FILLING
9.4 CARTRIDGE FILLING
9.5 OTHERS
10 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ONCOLOGY
10.3 INFECTIOUS DISEASES
10.4 CARDIOVASCULAR DISEASES
10.5 METABOLIC DISEASES
10.6 NEUROLOGY
10.7 UROLOGY
10.8 DERMATOLOGY
10.9 AUTOIMMUNE DISEASES
10.1 RESPIRATORY DISORDERS
10.11 OTHERS
11 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 SPECIALTY CLINICS
11.4 HOMECARE SETTING
11.5 OTHERS
12 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.4 ONLINE PHARMACY
12.5 OTHERS
13 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 PFIZER INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.2 GILEAD SCIENCES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FRESENIUS KABI USA (ASUBSIDIARY OF FRESENIUS SE & CO. KGAA).
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 ABBVIE INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 AMERICAN REGENT, INC. (A DAIICHI SANKYO GROUP COMPANY)
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 AMGEN INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 AMOMED PHARMA GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 ASTRAZENECA
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 BIOCRYST PHARMACEUTICALS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 BRISTOL-MYERS SQUIBB COMPANY
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 EISAI CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 EXELIXIS, INC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 GENENTECH, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS
16.15 HIKMA PHARMACEUTICALS PLC
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 MERCK SHARP & DOHME CORP., A SUBSIDIARY OF MERCK & CO., INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NEUREN PHARMACEUTICALS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 NOXOPHARM
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 SANOFI
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENT
16.2 TELIGENT
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, PIPELINE ANALYSIS
TABLE 2 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS
TABLE 3 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 YEARS)
TABLE 4 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA VIAL FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA SYRINGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA CARTRIDGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA ONCOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA INFECTIOUS DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA CARDIOVASCULAR DISEASE IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA METABOLIC DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA NEUROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA UROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DERMATOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA AUTOIMMUNE DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA RESPIRATORY DISORDERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA HOSPITALS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA SPECIALTY CLINICS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA HOMECARE SETTING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA DIRECT TENDER IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA RETAIL PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA ONLINE PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 34 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 35 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 41 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 MEXICO SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 43 MEXICO SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 MEXICO SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 MEXICO SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: NORTH AMERICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: PRODUCT LIFELINE CURVE
FIGURE 8 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MARKET END USER COVERAGE GRID
FIGURE 12 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 13 THE GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA IMMUNOASSAYS-GAMMA COUNTER MARKET
FIGURE 16 THE GRAPH BELOW SHOWS THE INCREASING PREVALENCE OF CHRONIC DISEASES IN 1995 TO FORECAST 2030 IN THE U.S.
FIGURE 17 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2020
FIGURE 18 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2020
FIGURE 22 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2020
FIGURE 26 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 29 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 30 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 32 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SNAPSHOT (2020)
FIGURE 34 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020)
FIGURE 35 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT (2021-2028)
FIGURE 38 NORTH AMERICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY SHARE 2020 (%)